InsidersTradesSigma
Follow the 康拓医疗 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 康拓医疗 has logged 9 public disclosures. Market capitalisation: €2.7bn. The latest transaction was disclosed on 23 April 2026 (Sale). Among the most active insiders: 朱海龙. All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€6m
9 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,800 of 29,063 companies
63.1
score / 100
Value45
Quality82
FCF yld2.6%
Earn yld3.8%
EV/EBITDA20.2x
ROE12%
Gross mgn79%
Net mgn28%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 April 2026
Declarations9 total
9 of 9 declarations
关于 康拓医疗
康拓医疗是一家在上海证券交易所上市的医疗保健和制药公司。该公司专注于创新医疗解决方案的开发和商业化。